Docket Number:10A-1020829
Inventor:Jyh-Yih Chen, Chang-Jer Wu and Han-Ning Hwang
IP Status:US, TW pending
Abstract:
Traditional antibiotics can not kill antibiotic-resistant bacteria. Injuries caused by drug-resistant bacterial infections, is that the condition has no cure. Antimicrobial peptides can promote wound healing, angiogenesis, inhibit the number of bacteria in the blood and reduce the amount of generation of immune-inflammatory gene expression and resistant strains. Provide a new direction for the treatment of wound infection.
Fields of Application:
This study's aim is to improve the common drawbacks of front burns after treatment, such as wounds slowly forming a hard crust, the need for pain medication for an extended time, and infections in wound healing.
Advantages when compared to the existing technologies:
Antimicrobial peptides have broad spectrum antibacterial activity in organisms. They are not affected by traditional antibiotic resistance mutant strains and do not easily produce drug-resistant strains. Because antimicrobial peptides are anti-inflammatory, anti-septic, anti-bacterial, and wound-tissue regenerating, they promote wound healing rates. After combination of biopolymer dressing developed in the laboratory; to form a thin film, increase their wounds attached, to prevent bacterial invasion and growth, easy to operate will also avoid the replacement of wound care material pain problems. That can replace traditional antibiotics, artificial skin and dead skin to use, in the future as humans burn wound treatment on the swing, it seems worth looking forward to space.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you.
